-
Mashup Score: 1
The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.
Source: www.dermatologyadvisor.comCategories: General Medicine News, CardiologistsTweet-
Cutaneous lupus erythematosus is associated with an increased risk of #ASCVD, according to a new study. Find out more: https://t.co/JwmVdfUYud #CardioX
-
-
Mashup Score: 0
UK participants who lived by airports or under a flight path had worse cardiac remodeling on CMR than those living elsewhere.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
People who live by airports or under flight paths have a higher risk of major CV events than those living elsewhere, according to new research in #JACC. Learn more in @TCTMD: https://t.co/ywiVyqAxrb
-
-
Mashup Score: 2
Dual diagnosis comes with increased risks of mortality, heart failure hospitalization
Source: www.medpagetoday.comCategories: General Medicine News, CardiologistsTweet-
People with ATTR-CA and #vhdAS had worse outcomes, new research shows. https://t.co/S1ywek2XX7 @medpagetoday
-
-
Mashup Score: 8
A cohort study with 14 years of follow-up found monogenic and polygenic mechanisms influencing LDL-C and incident T2D risk inversely associated.
Source: www.hcplive.comCategories: General Medicine News, Cardiology News and JournTweet-
Genetic predispositions that affect LDL #Cholesterol levels were associated with an increased risk of type 2 #Diabetes, according to new research. https://t.co/8uzl5vHI8D
-
-
Mashup Score: 1
The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
#HeartFailure patients treated with finerenone had a higher risk of early decline in kidney function, according to a new study in #JACC, but this did not impact the treatment’s benefit. @TCTMD reports on the findings: https://t.co/GdqSd1BY48
-
-
Mashup Score: 1
BAV patients are often excluded from TAVR trials, creating uncertainty about the best way to treat that population when aortic valve replacement is required. To learn more, researchers tracked CMS data from 2018 to 2022, presenting their findings in The Annals of Thoracic Surgery.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
#SAVR is linked to better long-term outcomes than #TAVR when treating patients w/ bicuspid aortic valves, according to a new study. https://t.co/JXZHiAjX57 @CardioBusiness
-
-
Mashup Score: 3MEK Inhibition Beneficial for Children With Subset of Severe Hypertrophic Cardiomyopathy - 7 day(s) ago
MONDAY, Jan. 13, 2025 (HealthDay News) — For children with severe hypertrophic cardiomyopathy caused by gain-of-function RAS/mitogen-activated protein kinase (
Source: www.healthday.comCategories: General Medicine News, CardiologistsTweet-
A recent #JACCBTS study found that trametinib decreases the risk of mortality and morbidity for children with severe #cvHCM. Get the details with @HealthDayTweets: https://t.co/oDfx88eiv4
-
-
Mashup Score: 0
UK participants who lived by airports or under a flight path had worse cardiac remodeling on CMR than those living elsewhere.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
People who live by airports or under flight paths have a higher risk of major CV events than those living elsewhere, according to new research in #JACC. Learn more in @TCTMD: https://t.co/ywiVyqAxrb
-
-
Mashup Score: 6Q&A: ACC unveils new staging system, decision pathway for myocarditis diagnosis, care - 8 day(s) ago
The American College of Cardiology recently issued an expert consensus document outlining a novel staging system and decision pathway for the diagnosis, treatment and longitudinal follow-up of patients with myocarditis.Healio spoke with Mark H. Drazner, MD, MSC, FACC, clinical chief of cardiology at UT Southwestern Medical Center and chair of the document’s writing committee, about the new
Source: www.healio.comCategories: General Medicine News, CardiologistsTweet-
Recently, ACC published an expert consensus decision pathway in #JACC for diagnosing and managing #Myocarditis. Dr. @MarkDrazner, chair of the document’s writing committee, spoke with @ScottBuzby about the new decision pathway in @CardiologyToday: https://t.co/N8bFxpdNgW
-
#HeartFailure patients treated with finerenone had a higher risk of early decline in kidney function, according to a new study in #JACC, but this did not impact the treatment’s benefit. @TCTMD reports on the findings: https://t.co/GdqSd1BY48